These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30382794

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies.
    Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT, Brummett RE.
    Am J Otolaryngol; 1984; 5(3):177-82. PubMed ID: 6742338
    [Abstract] [Full Text] [Related]

  • 23. Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?
    Al-Malky G, Suri R, Sirimanna T, Dawson SJ.
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):969-73. PubMed ID: 24703164
    [Abstract] [Full Text] [Related]

  • 24. Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
    Lopes J, Vidal-Folch N, Lundquist P, Schimmenti LA, Demirel N, Dean V, Olson J, Auth T, Butz M, Reed K, Wylam M, Balcom J, Boczek NJ, Hasadsri L.
    Pediatr Pulmonol; 2023 Mar; 58(3):819-824. PubMed ID: 36437230
    [Abstract] [Full Text] [Related]

  • 25. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.
    Mulheran M, Degg C, Burr S, Morgan DW, Stableforth DE.
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2502-9. PubMed ID: 11502521
    [Abstract] [Full Text] [Related]

  • 26. Symptom reporting compared with audiometry for the detection of cochleotoxicity in patients on long-term aminoglycoside therapy.
    Palmay L, Walker SA, Walker SE, Simor AE.
    Ann Pharmacother; 2011 May; 45(5):590-5. PubMed ID: 21521861
    [Abstract] [Full Text] [Related]

  • 27. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?
    Soulsby N, Bell S, Greville H, Doecke C.
    Intern Med J; 2009 Aug; 39(8):527-31. PubMed ID: 19220547
    [Abstract] [Full Text] [Related]

  • 28. Aminoglycoside exposure and renal function before lung transplantation in adult cystic fibrosis patients.
    Novel-Catin E, Pelletier S, Reynaud Q, Nove-Josserand R, Durupt S, Dubourg L, Durieu I, Fouque D.
    Nephrol Dial Transplant; 2019 Jan 01; 34(1):118-122. PubMed ID: 29684175
    [Abstract] [Full Text] [Related]

  • 29. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR, Tan KH.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD002009. PubMed ID: 16855982
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.
    O'Donnell EP, Scarsi KK, Scheetz MH, Postelnick MJ, Cullina J, Jain M.
    Int J Antimicrob Agents; 2010 Jul 19; 36(1):94-5. PubMed ID: 20382508
    [No Abstract] [Full Text] [Related]

  • 34. Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis.
    Prayle A, Watson A, Fortnum H, Smyth A.
    Thorax; 2010 Jul 19; 65(7):654-8. PubMed ID: 20627927
    [Abstract] [Full Text] [Related]

  • 35. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M, Hyman-Taylor P, Tan KH, Lewis S, Stableforth D, Knox A, Smyth A.
    Antimicrob Agents Chemother; 2006 Jul 19; 50(7):2293-9. PubMed ID: 16801404
    [Abstract] [Full Text] [Related]

  • 36. Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis.
    Crifo S, Antonelli M, Gagliardi M, Lucarelli N, Marcolini P.
    Int J Pediatr Otorhinolaryngol; 1980 Sep 19; 2(3):251-3. PubMed ID: 6821312
    [No Abstract] [Full Text] [Related]

  • 37. [Is it possible to recognize aminoglycoside ototoxicity early using evoked potentials?].
    Pechère JC, Bernard P.
    Ann Med Interne (Paris); 1980 Sep 19; 131(6):329-30. PubMed ID: 7469233
    [No Abstract] [Full Text] [Related]

  • 38. Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study.
    Jouret N, Van der Poel N, Verhulst S, Lammers M, Van Rompaey V, Jacquemin L, Van Hoorenbeeck K.
    Heliyon; 2024 Feb 15; 10(3):e25190. PubMed ID: 38333844
    [Abstract] [Full Text] [Related]

  • 39. Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.
    Stavroulaki P, Vossinakis IC, Dinopoulou D, Doudounakis S, Adamopoulos G, Apostolopoulos N.
    Arch Otolaryngol Head Neck Surg; 2002 Feb 15; 128(2):150-5. PubMed ID: 11843723
    [Abstract] [Full Text] [Related]

  • 40. Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients.
    Cies JJ, Varlotta L.
    Pediatr Pulmonol; 2013 Dec 15; 48(12):1190-4. PubMed ID: 23281228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.